JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (10): 1-8,28.doi: 10.6040/j.issn.1671-7554.0.2014.273
SUN Hui, ZHAO Lei, ZHEN Xi, WANG Shasha, HUANG Shanying, HE Hong, HU Qin
CLC Number:
[1] Juutilainen A, Lehto S, Ronnemaa T, et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects[J]. Diabetes Care, 2008, 31(4): 714-719. [2] Grundy S M, Howard B, Smith S Jr, et al. Prevention conference VI: Diabetes and cardiovascular disease executive summary conference proceeding for healthcare professionals from a special writing group of the American heart association[J]. Circulation, 2002, 105(18): 2231-2239. [3] Toso C, Emamaullee J A, Merani S, et al. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes[J]. Diabetologia, 2008, 51(11): 1937-1946. [4] Tse J, Martin-McNaulty B, Halks-Miller M, et al. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol[J]. Atherosclerosis, 1999, 144(2): 303-313. [5] Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis[J]. J Physiol Pharmacol, 2004, 55(3): 503-517. [6] Hsueh W, Abel E D, Breslow J L, et al. Recipes for creating animal models of diabetic cardiovascular disease[J]. Circ Res, 2007, 100(10): 1415-1427. [7] Nakashima Y, Plump A S, Raines E W, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree[J]. Arterioscler Thromb, 1994, 14(1): 133-140. [8] Abel E D, Kaulbach H C, Tian R, et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart[J]. J Clin Invest, 1999, 104(12): 1703-1714. [9] Gallagher E J, Sun H, Kornhauser C, et al. The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes[J]. Diabetes Metab Res Rev, 2014, 30(3): 191-200. [10] Naveiras O, Nardi V, Wenzel P L, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment[J]. Nature, 2009, 460(7252): 259-264. [11] Kadoglou N P, Moustardas P, Kapelouzou A, et al. The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis[J]. Eur J Histochem, 2013, 57(1): 3. [12] Goldberg I J, Dansky H M. Diabetic vascular disease: an experimental objective[J]. Arterioscler Thromb Vasc Biol, 2006, 26(8): 1693-701. [13] Tong C, Morrison A, Yan X, et al. Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes[J]. J Diabetes, 2010, 2(4): 267-274. [14] Kunjathoor V V, Wilson D L, LeBoeuf R C. Increased atherosclerosis in streptozotocin-induced diabetic mice[J]. J Clin Invest, 1996, 97(7): 1767-1773. [15] Candido R, Jandeleit-Dahm K A, Cao Z, et al. Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E-Deficient Mice[J]. Circulation, 2002, 106(2): 246-253. [16] Koïtka A, Cao Z, Koh P, et al. Angiotensin Ⅱ subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes[J]. Diabetologia, 2010, 53(3): 584-592. [17] Shen X, Bornfeldt K E. Mouse models for studies of cardiovascular complications of type 1 diabetes[J]. Ann N Y Acad Sci, 2007, 1103: 202-217. [18] Libby P. Inflammation in atherosclerosis[J]. Nature, 2002, 420(6917): 868-874. [19] Göran K, Hansson P L, Yan Usa Z. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis[J]. Circulation Research, 2002, 91(4): 281-291. [20] van der Wal A C, Becker A E, van der Loos C M, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Circulation, 1994, 89(1): 36-44. [21] Boring L, Gosling J, Cleary M, et al. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis[J]. Nature, 1998, 394(6696): 894-897. [22] Huber S A, Sakkinen P, Conze D, et al.Interleukin-6 exacerbates early atherosclerosis in mice[J]. Arterioscler Thromb Vasc Biol, 1999, 19(10): 2364-2367. [23] Wong N D, Patao C, Malik S, et al. Preventable coronaryheart disease events from control of cardiovascular risk factors in US adults with diabetes (Projections from Utilizing the UKPDS Risk Engine)[J]. Am J Cardiol, 2014, 113(8): 1356-1361. [24] Sherry C L, O'Connor J C, Kramer J M, et al. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK[J]. J Immunol, 2007, 178(2): 663-670. [25] Gough P J, Gomez I G, Wille P T, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice[J]. J Clin Invest, 2006, 116(1): 59-69. [26] Ding S, Zhang M, Zhao Y, et al. The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke[J]. Am J Med Sci, 2008, 336(1): 27-31. [27] Matsumura S, Iwanaga S, Mochizuki S, et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice[J]. J Clin Invest, 2005, 115(3): 599-609. [28] Newby A C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates[J]. Cardiovasc Res, 2006, 69(3): 614-624. [29] Allaire E, Forough R, Clowes M, et al. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model[J]. J Clin Invest, 1998, 102(7): 1413-1420. [30] Rouis M, Adamy C, Duverger N, et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E–deficient mice[J]. Circulation, 1999, 100(5): 533-540. [31] Lemaître V, Soloway P D, D'Armiento. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1[J]. Circulation, 2003, 107(2): 333-338. |
[1] | FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31. |
[2] | YIN Ni, YANG Guanlin, JIANG Junwen, WANG Chuntian, WANG Fengyao, JIA Lianqun, GAO Xiaoyu, PAN Jiaxiang, LI Qin, LI Jia, FENG Yuanjie, GAO Yuzhu, ZHOU He, ZHANG Zhe. A reliable system to assess atherosclerosis model of Bama minipigs [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 1-5. |
[3] | LI Shuai, WANG Yalin, SUN Zhongwen, ZHU Meijia. Expression changes and mechanism of Nod-like receptor protein 3 inflammasome in the cerebral microvascular endothelial cells in type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 6-11. |
[4] | WEI Dandan, ZHANG Cheng. Effects of the overexpression of type 4 angiotensin receptor on the formation of atherosclerotic lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 1-5. |
[5] | PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63. |
[6] | LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37. |
[7] | WANG Dan, QI Hengtao, SUN Shuzhen. Changes of carotid artery structure and function in children with primary nephrotic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 88-91. |
[8] | SUN Pengfei, MENG Xiao, ZHANG Kai, LI Li. The effect of resistin-like molecule β on the vulnerability of atherosclerotic plaques in ApoE-/- mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 1-4. |
[9] | Muhadasi TUERXUNYIMING, Patamu MOHEMAITI, Tuolanguli MAIMAITIKUERBAN. Association of CDKAL1 rs10946398 C/A polymorphism with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 75-85. |
[10] | YU Ning, GAO Yanyan, XIAN Yuxin, NIU Jiapeng, LI Li, WANG Jing, CAO Caixia. Effect of exenatide on serum chemerin level and liver fat contents in type 2 diabetes mellitus combined with non-alcoholic fatty liver disease patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 51-55. |
[11] | YU Lu, LIU Qiang. Introvoxel incoherent motion MR imaging for the assessment of renal function of diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 68-71. |
[12] | YIN Xiaofang, GE Haibo. Epidemiological features of inpatients suffered from pulmonary tuberculosis with diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 58-61. |
[13] | ZHANG Dongqing, WANG Yong, CHEN Shouzhen, ZHU Yaofeng, SHI Benkang. Changes on the expressions of alpha1-adrenergic receptor and nerve growth factor and their effects on urethral function in diabetic rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 30-34. |
[14] | LIU Yanxun, LIU Jia, ZHANG Tao, WANG Lu, XUE Fuzhong, WANG Ping. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 83-86. |
[15] | WANG Xiaofei, WANG Chengwei, WANG Zhigang, DING Xuan, WANG Minqing. Application of enterprise stent in atherosclerotic vertebral-basilar arterial stenosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 44-48. |
|